France fines Sanofi for stifling generic Plavix
Sanofi-Aventis tried to limit access to generic rivals to Plavix (Credit: Trounce/Wikimedia Commons)
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now